EICHOR
● Not Yet Recruiting
Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
Condition: Cervical Intraepithelial Neoplasia Grade 2 (CIN2) · Cervical Intraepithelial Neoplasia Grade 2 · CIN2 · Sponsor: University Hospital Tuebingen
About this study
The study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This will be confirmed by examining tissue samples under a microscope (histopathological examination).
This description comes directly from the study's public registry record.
Talk to the study team
Martin Weiss, Prof. Dr. · +49 7071 29 82211 · martin.weiss@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
Locations (1)
| University Hospital Tuebingen, Department of Women's Health | Tübingen, Baden-Wurttemberg, Germany | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07730645